The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUC.L Regulatory News (NUC)

  • There is currently no data for NUC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) Nucleus Financial Group PLC

16 Dec 2020 11:55

RNS Number : 8777I
Nucleus Financial Group PLC
16 December 2020
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Nucleus Financial Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Nucleus Financial Group plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

15 December 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

a) Interests held by directors of Nucleus Financial Group plc (and their close relatives and related trusts)

 

Director

Number of ordinary shares

Percentage of issued share capital (excluding share options/awards set out below)

Angus Samuels1

53,409

0.069

David Ferguson1

1,810,188

2.367

Stuart Geard1

954,625

1.248

John Levin

Nil

Nil

Tracy Dunley-Owen

Nil

Nil

Margaret Hassall

Nil

Nil

Alfio Tagliabue

Nil

Nil

Jonathan Polin

Nil

Nil

TOTAL

2,818,222

3.685

 

1 Inclusive of holdings of close relatives

 

b) Interests held by directors of Nucleus Financial Group plc in the Nucleus Financial Group plc share incentive plan ("SIP")

 

Director

Interest

David Ferguson

4,896*

 

*Includes the purchase of 168 ordinary shares under the SIP, which is subject to a separate dealing disclosure under Rule 8 of the City Code on Takeovers and Mergers

 

c) Long Term Incentive Plan ("LTIP") awards held by directors of Nucleus Financial Group plc (and their close relatives and related trusts)

 

The Nucleus Financial Group plc LTIP comprises conditional awards of nil cost options over ordinary shares to selected members of the senior management team (including the executive directors) and certain other employees, which vest on the achievement of specified performance targets and continuous employment over a certain period of time (the vesting period).

 

(i) LTIP awards held by David Ferguson

 

Date of grant

Exercise price

Vesting date

Interest

26 July 2018

Nil

26 July 2021

243,441

3 April 2019

Nil

3 April 2022

199,786

19 May 2020

Nil

19 May 2023

311,715

Total

754,942

 

(ii) LTIP awards held by Stuart Geard

 

Date of grant

Exercise price

Vesting date

Interest

26 July 2018

Nil

26 July 2021

164,180

3 April 2019

Nil

3 April 2022

134,738

19 May 2020

Nil

19 May 2023

233,000

Total

531,918

 

 

d) Interests held by RBC cees Trustee Limited as the trustee of the NFG Limited Employment Benefit Trust 2010

 

Name

Number of ordinary shares

Percentage of issued ordinary share capital

RBC cees Trustee Limited as the trustee of the NFG Limited Employment Benefit Trust 2010

540,000

0.706

 

 

e) Interests held by concert parties

 

Name

Number of ordinary shares

Percentage of issued ordinary share capital

Sanlam UK Limited

39,914,760

52.194

 

 

f) Interests held by connected advisers of Nucleus Financial Group plc

 

No interests, short positions or rights to subscribe are held by Nucleus Financial Group plc's connected advisers Shore Capital and Corporate Limited, Shore Capital Stockbrokers Limited, or Craven Street Capital Limited, or the persons affiliated with them, who are not exempt principal traders for the purposes of the Rule 8 of the Code.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

16 December 2020

Contact name:

Michelle Bruce, Company Secretary

Telephone number:

+44 (0)131 226 9800

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEETFBBTMTIBBRM
Date   Source Headline
3rd Dec 202011:07 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
2nd Dec 20205:35 pmRNSStatement re Nucleus Financial Group plc
2nd Dec 202012:07 pmRNSStatement regarding a Possible Offer
17th Nov 20207:00 amRNSDirector/PDMR Shareholding
2nd Nov 20207:00 amRNSAcquisition of certain assets of OpenWealth
23rd Oct 20207:00 amRNSQ3 2020 AUA update
13th Oct 20201:35 pmRNSDirector/PDMR Shareholding
28th Sep 202012:18 pmRNSDirector/PDMR Shareholding
15th Sep 20209:26 amRNSDirector/PDMR Shareholding
8th Sep 20207:00 amRNSInterim Results
14th Aug 20207:00 amRNSNotice of Interim Results
14th Aug 20207:00 amRNSDirector/PDMR Shareholding
24th Jul 20207:00 amRNSQ2 2020 AUA update
14th Jul 20207:00 amRNSDirector/PDMR Shareholding
16th Jun 202012:10 pmRNSDirector/PDMR Shareholding
20th May 20203:44 pmRNSGrant of long term incentive awards
20th May 20201:14 pmRNSResult of AGM
14th May 20207:00 amRNSDirector/PDMR Shareholding
15th Apr 20204:13 pmRNSNotice of AGM
15th Apr 20202:15 pmRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSFinal Results
23rd Mar 20204:40 pmRNSCovid-19 and trading update
17th Mar 20202:28 pmRNSDirector/PDMR Shareholding
26th Feb 20207:00 amRNSNon-Executive Director Changes
13th Feb 20204:15 pmRNSDirector/PDMR Shareholding
31st Jan 20207:00 amRNSQ4 2019 AUA update
29th Jan 20202:20 pmRNSHolding(s) in Company
15th Jan 20203:43 pmRNSDirector/PDMR Shareholding
16th Dec 20192:37 pmRNSDirector/PDMR Shareholding
22nd Nov 20193:50 pmRNSDirector/PDMR Shareholding
14th Nov 201912:00 pmRNSDirector/PDMR Shareholding
25th Oct 20197:00 amRNSQ3 2019 AUA update
18th Oct 20195:38 pmRNSDirector/PDMR Shareholding
16th Oct 201911:15 amRNSDirector/PDMR Shareholding
17th Sep 20194:45 pmRNSDirector/PDMR Shareholding
10th Sep 20197:00 amRNSInterim Results
16th Aug 20197:00 amRNSNotice of Results
15th Aug 20193:58 pmRNSDirector/PDMR Shareholding
26th Jul 20197:00 amRNSQ2 2019 AUA update
16th Jul 20199:00 amRNSDirector/PDMR Shareholding
14th Jun 20194:48 pmRNSDirector/PDMR Shareholding
23rd May 201911:35 amRNSResult of AGM
17th May 20197:00 amRNSDirector/PDMR Shareholding
29th Apr 20197:00 amRNSQ1 2019 AUA update
16th Apr 20191:58 pmRNSDirector/PDMR Shareholding
11th Apr 20192:24 pmRNSPosting of Annual Report and Notice of AGM
4th Apr 20198:20 amRNSHolding(s) in Company
3rd Apr 20191:50 pmRNSGrant of long term incentive awards to PDMRs
2nd Apr 20197:00 amRNSPreliminary results
14th Mar 20194:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.